A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients
Clinical trial NCT05941793 · COMPLETED
Trial details
- NCT number
- NCT05941793
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2024-08-12
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.